Johanna E E Pouw

5PUBLICATIONS
11CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 13, 2026
PET pharmacokinetics of [¹⁸F]F-AraG as a marker of T cell activation during immunotherapy with a STING agonist with and without anti-PD-1.

|Jun 17, 2024
Exploring the predictive potential of programmed death ligand 1 expression in healthy organs and lymph nodes as measured by 18F-BMS986-192 PET: pooled analysis of data from four solid tumor types.

Iris H C Miedema, Johanna E E Pouw, Anne Kwakman

|Feb 01, 2024
First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PET.

Johanna E E Pouw, Sayed M S Hashemi, Marc C Huisman

|Dec 09, 2023
89Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs.

Iris H C Miedema, Jessica E Wijngaarden, Johanna E E Pouw

|Aug 07, 2021
Irreversible Electroporation and Nivolumab Combined with Intratumoral Administration of a Toll-Like Receptor Ligand, as a Means of In Vivo Vaccination for Metastatic Pancreatic Ductal Adenocarcinoma (PANFIRE-III). A Phase-I Study Protocol.

Bart Geboers, Florentine E F Timmer, Alette H Ruarus

Pageof 1

Frequent Collaborators

2 joint publications

C Willemien Menke-van der Houven van Oordt

2 joint publications

Iris H C Miedema

1 joint publications

Bart Geboers

1 joint publications

Florentine E F Timmer